Temporal dynamics of the vaginal microbiome and host immune markers before, during, and after metronidazole treatment for bacterial vaginosis

Abstract excerpt

ABSTRACT This study analyzed metagenomic and immune marker profiles of seven individuals before, during, and after a 7-day course of metronidazole treatment for bacterial vaginosis (BV). Treatment reduced BV-associated bacteria and immune marker levels, with distinct early (days 1–4) and late (days 5–7) phases. Post-treatment variability in microbial and immune marker profiles demonstrated a rapid resurgence of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gut microbiota and health
• Share to Reproductive tract infections research
• Share to Urinary Tract Infections Management